| Previous Close | 50.85 |
| Open | 50.73 |
| Bid | 0.00 x |
| Ask | 0.00 x |
| Day's Range | 50.49 - 50.93 |
| 52 Week Range | 37.38 - 51.13 |
| Volume | 7,980,288 |
| Avg. Volume | 6,362,514 |
| Market Cap | 88.22B |
| Beta | 1.54 |
| PE Ratio (TTM) | 52.90 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 1.06 (2.08%) |
| Ex-Dividend Date | 2017-07-12 |
| 1y Target Est | N/A |
- Market Realist•2 days ago
Abiomed Impella Quality Program Will Boost Demand in Fiscal 2018
To improve clinical outcomes and increase the number of patients treated in the United States using Impella, Abiomed has launched the Abiomed Impella Quality Program.
- Market Realist•2 days ago
Behind the Major Drivers of JNJ’s Medical Device Growth
Johnson & Johnson (JNJ) reported Medical Devices segment sales of ~$6.7 billion in 2Q17, compared with $6.4 billion in 2Q16.
- Market Realist•2 days ago
Inside Abiomed’s Profit Margin Expectations for Fiscal 2018
For fiscal 2018 (ended March 31, 2018), Abiomed (ABMD) has projected that its operating margins will be in the range of 22%–24%.
